About Tirzepatide
Tirzepatide is a novel dual GIP/GLP-1 receptor agonist, currently under investigation for its potential role in metabolic and weight-related research applications. Its mechanism of action—simultaneously activating multiple incretin receptors—has made it a major focus of clinical study. While not approved for human consumption, Tirzepatide’s unique pharmacological profile has attracted global research interest.
By linking your experiments with verified peptide supply, you can ensure that your research is consistent and reproducible.
Product Details
Form: Lyophilized peptide powder
Verified purity: ≥99% (independent third-party tested)
Storage: Keep vials in a cool, dry location. Once reconstituted, refrigerate to preserve stability.
Shipping: Same-day dispatch on USA orders; tracked shipping to Canada
We offer multiple vial sizes and kit options to support different research needs. Every order is handled with the same level of care and precision, making Royal Peptides a trusted supplier for labs that value consistency.
Key Features:
✅ 10 vials per kit, each fully dosed
✅ >99% purity (verified via third-party COA)
✅ Manufactured in cGMP-certified facilities
✅ Ideal for GLP-1, GIP, and incretin-focused studies
✅ Ships from USA or Canada-based fulfillment centers
✅ Bulk discounts & secure delivery guaranteed
Your message has been sent
Oricore Peptides 